Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

ALVOTECH

Summary

Alvotech is a biotech company specializing in the development and manufacture of biosimilar medicines.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 1.72 B

Avg. Deal Size£ 859 M

Market Context

Senior Management

Robert Wessman
Chairman and CEO
Mark Levick
CEO
Joel Morales
CFO

Sort

stephanie carrington

Managing Director at ICR

PR Consultant

New York

Shared Deal

1 For

£ 1.70 B

Total Value

sean leous

Senior Vice President at ICR

PR Consultant

Shared Deal

1 For

£ 1.70 B

Total Value

kuo hua lee

Paralegal at Cooley

Lawyer

San Francisco

Shared Deal

1 For

£ 1.70 B

Total Value

barbara mirza

Partner at Cooley

Lawyer

Los Angeles

Shared Deal

1 For

£ 1.70 B

Total Value

stella sarma

Special Counsel at Cooley

Lawyer

Brussels

Shared Deal

1 For

£ 1.70 B

Total Value

ivor elrifi

Partner at Cooley

Lawyer

New York

Shared Deal

1 For

£ 1.70 B

Total Value

sharon connaughton

Special Counsel at Cooley

Lawyer

Washington D.C.

Shared Deal

1 For

£ 1.70 B

Total Value

div gupta

Partner at Cooley

Lawyer

New York

Shared Deal

1 For

£ 1.70 B

Total Value

sonia nath

Partner at Cooley

Lawyer

Washington D.C.

Shared Deal

1 For

£ 1.70 B

Total Value

stacey bradford

Special Counsel at Cooley

Lawyer

Washington D.C.

Shared Deal

1 For

£ 1.70 B

Total Value

chi vo kavanaugh

Associate at Cooley

Lawyer

London

Shared Deal

1 For

£ 1.70 B

Total Value

vlad herta

Associate at Cooley

Lawyer

London

Shared Deal

1 For

£ 1.70 B

Total Value

See 63 dealmakers that match your search results with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy